Clinical trials on medicinal products: all transition applications must be submitted via the CTIS portal
https://ansm.sante.fr/actualites/essais-cliniques-de-medicaments-toutes-les-demandes-de-transition-doivent-etre-deposees-sur-le-portail-ctis
Q&A: Good clinical practice (GCP)
https://www.ema.europa.eu/en/human-regulatory-overview/research-and-development/compliance-research-and-development/good-clinical-practice/qa-good-clinical-practice-gcp
EU medicines agencies reflect on lessons learned from COVID-19
https://www.ema.europa.eu/en/news/eu-medicines-agencies-reflect-lessons-learned-covid-19
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-27-30-november-2023
ANSM publishes the 2022 haemovigilance activity report
https://ansm.sante.fr/actualites/lansm-publie-le-rapport-dactivite-dhemovigilance-2022
PRAC recommendations on safety signals
https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/signal-management/prac-recommendations-safety-signals